We are live on
!
Find out more
Marshall Wace North America Portfolio holdings
AUM
$23.5B
Turnover
51.87%
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.49%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20B
AUM Growth
+$1.88B
(+10%)
Cap. Flow
+$1.7B
Cap. Flow
% of AUM
8.49%
Top 10 Holdings %
Top 10 Hldgs %
14%
Holding
1,901
New
565
Increased
401
Reduced
415
Closed
510
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$328M |
| 2 |
Citigroup
C
|
+$183M |
| 3 |
Cboe Global Markets
CBOE
|
+$152M |
| 4 |
McDonald's
MCD
|
+$130M |
| 5 |
Restaurant Brands International
QSR
|
+$127M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$285M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$143M |
| 3 |
CVS Health
CVS
|
+$142M |
| 4 |
T-Mobile US
TMUS
|
+$123M |
| 5 |
Meta Platforms (Facebook)
META
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.97% |
| 2 | Consumer Discretionary | 15.44% |
| 3 | Technology | 14.79% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 11.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.93T
| $497M | 2.49% |
5,441,701
+3,590,771
| +194% | +$328M |
2017 Q1
4 quarters
|
|
2
S&P Global
SPGI
$127B
| $316M | 1.58% |
1,654,401
+386,933
| +31% | +$71.4M |
2017 Q1
4 quarters
|
|
3
Boston Scientific
BSX
$64.3B
| $315M | 1.58% |
11,516,273
+1,205,496
| +12% | +$32.8M |
2017 Q1
4 quarters
|
|
|
4
Meta Platforms (Facebook)
META
$1.81T
| $303M | 1.52% |
1,898,988
-596,488
| -24% | -$107M |
2013 Q3
18 quarters
|
|
5
Zoetis
ZTS
$32.8B
| $260M | 1.3% |
3,109,531
-468,376
| -13% | -$36.9M |
2013 Q2
19 quarters
|
|
6
Johnson & Johnson
JNJ
$616B
| $260M | 1.3% |
2,026,198
-41,155
| -2% | -$5.56M |
2017 Q2
3 quarters
|
|
7
Quest Diagnostics
DGX
$25.9B
| $245M | 1.23% |
2,443,684
+586,085
| +32% | +$60M |
2017 Q1
4 quarters
|
|
8
Alibaba
BABA
$271B
| $211M | 1.06% |
1,149,619
+378,522
| +49% | +$71.3M |
2017 Q2
3 quarters
|
|
9
Agilent Technologies
A
$48.8B
| $204M | 1.02% |
3,042,427
+1,181,929
| +64% | +$82.8M |
2013 Q2
19 quarters
|
|
10
CoStar Group
CSGP
$13.1B
| $186M | 0.93% |
5,120,370
+1,269,290
| +33% | +$43.8M |
2017 Q1
4 quarters
|
|
11
UnitedHealth
UNH
$360B
| $183M | 0.92% |
857,248
+176,433
| +26% | +$40.3M |
2017 Q1
4 quarters
|
|
12
Las Vegas Sands
LVS
$24.6B
| $183M | 0.92% |
2,543,868
+635,529
| +33% | +$46.6M |
2017 Q3
2 quarters
|
|
13
DELISTED
Sealed Air
SEE
| $182M | 0.91% |
4,259,463
+1,460,747
| +52% | +$66M |
2017 Q1
4 quarters
|
|
14
Broadcom
AVGO
$1.57T
| $167M | 0.84% |
7,106,320
+2,587,940
| +57% | +$65.2M |
2017 Q2
3 quarters
|
|
|
15
Citigroup
C
$208B
| $164M | 0.82% |
+2,429,984
| New | +$183M |
2018 Q1
0 quarters
|
|
16
Pfizer
PFE
$169B
| $161M | 0.81% |
4,785,044
-2,060,771
| -30% | -$70.8M |
2013 Q2
19 quarters
|
|
|
ABMD
17
DELISTED
Abiomed Inc
ABMD
| $156M | 0.78% |
537,242
+59,624
| +12% | +$15.1M |
2017 Q1
4 quarters
|
|
|
18
Restaurant Brands International
QSR
$26.1B
| $155M | 0.78% |
2,722,977
+2,144,397
| +371% | +$127M |
2017 Q1
4 quarters
|
|
19
Amazon
AMZN
$2.7T
| $145M | 0.72% |
1,999,440
+1,419,040
| +244% | +$101M |
2013 Q3
18 quarters
|
|
|
20
McDonald's
MCD
$172B
| $144M | 0.72% |
921,943
+788,385
| +590% | +$130M |
2013 Q3
18 quarters
|
|
21
PTC
PTC
$21B
| $144M | 0.72% |
1,847,376
-276,608
| -13% | -$20.2M |
2017 Q1
4 quarters
|
|
|
22
Cboe Global Markets
CBOE
$32.9B
| $143M | 0.71% |
+1,248,922
| New | +$152M |
2018 Q1
0 quarters
|
|
23
Constellation Brands
STZ
$22.2B
| $141M | 0.71% |
618,667
+326,615
| +112% | +$71.9M |
2017 Q1
4 quarters
|
|
24
Abbott
ABT
$181B
| $139M | 0.69% |
2,314,252
+242,301
| +12% | +$14.6M |
2013 Q3
18 quarters
|
|
25
Novartis
NVS
$286B
| $135M | 0.67% |
1,857,661
+266,161
| +17% | +$20.3M |
2017 Q1
4 quarters
|
|
Similar funds
NAM
Marshall Wace North America's Q1 2018 Portfolio in Review
As of Q1 2018, Marshall Wace North America held 1,901 positions worth $20B, up 10% from $18.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace North America deployed $1.7B of net new capital in Q1 2018, opening 565 new positions and adding to 401 existing holdings. Its largest new stake was Citigroup: 2,429,984 shares worth $164M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $285M trimmed.
- Marshall Wace North America's largest Q1 2018 buy was Citigroup: 2,429,984 shares worth $164M.
- Marshall Wace North America added most to Microsoft in Q1 2018, an estimated $328M increase.
- Marshall Wace North America's biggest Q1 2018 reduction was Alphabet (Google) Class A, cutting an estimated $285M.
- Marshall Wace North America fully exited Manulife Financial in Q1 2018, selling an estimated $83.9M.
- Marshall Wace North America's ten largest holdings make up 14% of its $20B portfolio in Q1 2018.
- Marshall Wace North America opened 565 new positions and closed 510 in Q1 2018.
- Marshall Wace North America's portfolio value rose 10% quarter-over-quarter to $20B.
Based on Marshall Wace North America's 13F filing for Q1 2018, filed 15 May 2018.